“The strong R&D strength of ITO Medical and the high level of AI products have been the most rigorous tests in nearly 100 top three hospitals in China,†said the leaders of hundreds of countries at the 2018 Asia Pacific Medical Technology Forum in Singapore. In the keynote speech entitled “AI Empowering Healthcareâ€, Dr. Fang Wei, the person in charge of the regulatory agency and the hospital manager, said: “We sincerely look forward to working with every partner at home and abroad to promote The development of medical artificial intelligence industry, the construction of intelligent hospitals with advanced AI applications, empowering the global medical industry."
Dr. Fang Wei said that medical artificial intelligence is bringing great changes to clinical medicine. While liberating clinicians from heavy mechanical labor, AI is moving from single-function image detection function to “MDT decision-making†and fully participates. The clinical diagnosis and treatment process has become the "second brain" of doctors, and promotes the comprehensive development of clinical diagnosis and treatment. The rich experience of Yitu Medical in mainland China shows that the use of medical AI technology to build smart hospitals has become the trend of the times.
The 2018 Asia Pacific MedTech Forum 2018 (APACMed) is the most professional, largest and most professional medical technology conference in Southeast Asia. It is open to professionals only. The conference has gathered more than 600 conferences. Government officials, regulators, hospital administrators and technical experts from various Asian countries have discussed the frontiers of medicine.
Dr. Fang Cong delivered a keynote speech
After the meeting, Dr. Fang and the Ministry of Health of Singapore, Singapore Health Science Bureau, Singapore Science and Technology Research Bureau, National University of Singapore Medical Organization (NUHS), Singapore Health Group (SingHealth MTO), Raffles Medical Group (Raffles Medical Group) and many more Various departments held closed-door meetings and conducted in-depth discussions on the details of medical artificial intelligence, cooperation methods, medical data cooperation, and privacy protection, and accepted an exclusive interview with China International TV Network (CGTN).
It is understood that while maintaining close communication with the Singapore regulatory authorities, Etu Medical is working with a number of public hospitals and private medical groups in Singapore to introduce advanced medical artificial intelligence into the Singapore healthcare system to alleviate the labor shortage it faces. And the threat of chronic disease.
According to estimates by the Ministry of Health of Singapore, by 2020, Singapore’s healthcare system will need to add 30,000 health care workers to reduce the labor force caused by the aging population in Singapore and the increase in medical demand caused by chronic diseases, and medical expenditure will continue to grow rapidly. It has brought great pressure on the health insurance system, and it is imperative to introduce AI to improve the operational efficiency of medical institutions.
In the previous September, Channel News Asia (CNA) from Singapore has taken several months to visit many medical institutions such as Hangzhou Medical Headquarters and Zhejiang People's Hospital, with Yitu Medical as the global medical labor. Smart representative of the company, the filming of the "Algorithms: How They Rule Our World" feature documentary. China is becoming a leader in the development and practice of medical artificial intelligence products in the world.
To Yitu Healthcare : Why is Singapore?
In the post-meeting interview, when talking about the reasons why Yitu Medical chose Singapore as the premiere of Southeast Asia, Dr. Fang said: The reasons are mainly as follows:
First of all, according to the technical strength, product level and cooperation sincerity of Etu Medical, it has been unanimously recognized by the Singapore Health Bureau and major medical groups. As the top medical AI company in China, it is developed by Yitu Medical. aiTM medical intelligent full-stack products have successfully landed more than 100 top three hospitals in mainland China. They have accumulated rich practical experience in the research and development, engineering, deployment, operation and maintenance of AI systems, and can provide medical systems. Complete closed-loop solution.
Dr. Fang Wei took the latest X-ray intelligent diagnosis system released by Yitu Medical in September as an example. The system uses the tens of thousands of real breast mammography data of many top three hospitals in the country to realize the second generation of mammography images. The grade reading has a number of functions such as gland typing, comprehensive lesion detection, symptom description, intelligent BI-RADS typing, etc., and can automatically generate structured reports for use by imaging physicians. This system was praised as the "highest level of similar products in China" by Professor Peng Weijun, the top imaging expert in China and the director of the Department of Radiology, Fudan University Cancer Hospital.
In the field of lung cancer, care developed by Yitu Medical. The aiTM lung cancer imaging intelligent diagnosis system has also been widely welcomed by experts all over the country. In many hospitals, the use of artificial intelligence systems for reading has become a daily operation of doctors. It is only in Wuhan Union Hospital, and it has been less than one year. Providing intelligent image interpretation services for nearly 100,000 patients, the clinical adoption rate of structured reports issued by AI has exceeded 92%.
Secondly, Singapore has a well-established and high-quality health care system. Its medical technology and regulatory level are obvious to all. The local government is constantly striving to improve the accessibility, quality and affordability of medical services in Singapore, and health care spending continues to grow. In response to the current hottest medical artificial intelligence in the industry, the Singapore government has also released the Singapore Artificial Intelligence Strategy (AI Singapore). The Singapore Ministry of Health has also introduced corresponding access regulations and privacy regulations, and a strict regulatory environment. It will greatly promote the standard development of the medical artificial intelligence industry.
Dr. Fang Wei emphasized that the medical artificial intelligence industry is a relatively frontier in the world, and the strict regulatory environment is a huge policy favor for companies that want to seriously engage in the medical AI industry. Singapore is a global leader in this field. It has strict regulations and paths for product access, functional validation, and data privacy protection. Vision Medical has always adhered to strict medical ethics and full compliance with local laws and regulations. Obey, and get the gold from the beginning of the yellow sand. I believe that the products and teams of the company can meet the international challenges of AI products.
China’s wisdom to sail to the sea can be expected
With the rapid development of China's medical artificial intelligence industry, China's medical AI companies represented by Yitu Medical have taken the lead in product development and landing. How to promote advanced medical AI to set sail for the global medical industry?
In this regard, Dr. Fang said that for Chinese AI companies, the cultivation of internal strength is the primary task. The deep understanding of clinical needs, perfect product functions, friendly human-machine coordination and other elements are indispensable. Only when the AI ​​application is truly put into the clinic, it is iteratively upgraded in the clinic and integrated into the clinical workflow, which can help clinicians improve labor efficiency and improve the level of hospital intelligence, so that they can be clinically recognized.
After the meeting, as a representative of China Medical AI Enterprise, Dr. Yitu Medical and his team and the Ministry of Health of Singapore, Singapore Health Science Bureau, Singapore Science and Technology Research Institute, National University Medical Organization (NUHS), Singapore Health Group (SingHealth MTO), Lai Raffles Medical Group and other departments held closed-door meetings to discuss in depth the details of medical artificial intelligence, cooperation methods, medical data cooperation, privacy protection, etc., and reached some cooperation agreements. .
It is also understood that the internationalization strategy of Etu Medical has been steadily advancing, and it is stable and stable. As an important layout of the globalization strategy, based on the Singapore branch established in early 2018, Etu Medical will build a new Singapore R&D center during the year to support the internationalization of AI product development by bringing together local and international high-end talents. Service localization process.
Feed Additives,Feed Grade Nutrition Supplement,Amino Acid For Animal Feed,Feed Grade Additive Amino Acid
NANYANG CHENGPENG PHARMACEUTICAL CO.,LTD , https://www.chppharm.com